Erratum: Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer (International Journal of Oncology (2016) 48 (1155-1164) DOI: 10.3892/ijo.2016.3319);Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer

International Journal of Oncology

Volumn 48, Issue 3, 2016, Pages 1155-1164

  Li, Wentong ^a   Liu, Chuanliang ^b   Zhao, Chunling ^a   Zhai, Limin ^a   Lv, Shijun ^a,b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

Erk; Invasion; MiR 30a 5p; Triple negative breast cancer; 3 integrin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA3 INTEGRIN; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; MICRORNA 30A 5P; MITOGEN ACTIVATED PROTEIN KINASE 1; RENILLA LUCIFERIN 2 MONOOXYGENASE; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; VITRONECTIN RECEPTOR; 3' UNTRANSLATED REGION; ETS1 PROTEIN, HUMAN; ITGB3 PROTEIN, HUMAN; MIRN30 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BIOINFORMATICS; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; DRUG TARGETING; ECTOPIC EXPRESSION; EMBRYO; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MDA MB 468 CELL LINE; METASTASIS INHIBITION; MIGRATION INHIBITION; NUCLEOTIDE BINDING SITE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STABLE EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; VIRAL GENE DELIVERY SYSTEM; WILD TYPE; BINDING SITE; BREAST TUMOR; CELL MOTION; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MCF-7 CELL LINE; METABOLISM; METASTASIS; PLASMID; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BINDING SITES; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA3; MCF-7 CELLS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLASMIDS; PROTO-ONCOGENE PROTEIN C-ETS-1; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84959036308     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2021.5169     Document Type: Erratum

References (34)

1. Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF, Schiemann WP and Sossey-Alaoui K. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat 142: 341-353, 2013
2. Barcus CE, Keely PJ, Eliceiri KW and Schuler LA. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. J Biol Chem 288: 12722-12732, 2013
3. Wang Y, Shenouda S, Baranwal S, Rathinam R, Jain P, Bao L, Hazari S, Dash S and Alahari SK. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis. Mol Cancer 10: 84, 2011
4. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001
5. Salvo E, Garasa S, Dotor J, Morales X, Pelαez R, Altevogt P and Rouzaut A. Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-smallcell lung cancer. Mol Cancer 13: 112, 2014
6. Li N, Zhang JP, Guo S, Min J, Liu LL, Su HC, Feng YM and Zhang HL. Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer. Mol Biol Rep 39: 3029-3035, 2012
7. Parvani JG, Gujrati MD, Mack MA, Schiemann WP and Lu ZR. Silencing β3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer. Cancer Res 75: 2316-2325, 2015
8. Huveneers S and Danen EH. Adhesion signaling-crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069, 2009
9. Raymond K, Faraldo MM, Deugnier MA and Glukhova MA. Integrins in mammary development. Semin Cell Dev Biol 23: 599-605, 2012
10. Harquail J, Benzina S and Robichaud GA. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer biomarkers: section. Dis Markers 11: 269-280, 2012
11. de Krijger I, Mekenkamp LJ, Punt CJ and Nagtegaal ID. MicroRNAs in colorectal cancer metastasis. J Pathol 224: 438-447, 2011
12. Shi M and Guo N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat Rev 35: 328-334, 2009
13. Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G and Yang Q. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene 33: 3119-3128, 2014
14. Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, deVere White RW and Kung HJ. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene 33: 2495-2503, 2014
15. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zöllner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W and Hahn SA. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33: 732-739, 2012
16. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG and Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poorprognosis breast cancer. Cancer Cell 15: 9-20, 2009
17. Heckman KL and Pease LR. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc 2: 924-932, 2007
18. Knowles LM, Gurski LA, Engel C, Gnarra JR, Maranchie JK and Pilch J. Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis. Cancer Res 73: 6175-6184, 2013
19. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002
20. Hynes RO. Targeted mutations in cell adhesion genes: What have we learned from them? Dev Biol 180: 402-412, 1996
21. Morgan MR, Humphries MJ and Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8: 957-969, 2007
22. Gehler S, Ponik SM, Riching KM and Keely PJ. Bi-directional signaling: Extracellular matrix and integrin regulation of breast tumor progression. Crit Rev Eukaryot Gene Expr 23: 139-157, 2013
23. Truong HH, Xiong J, Ghotra VP, Nirmala E, Haazen L, Le Dévédec SE, Balcio?lu HE, He S, Snaar-Jagalska BE, Vreugdenhil E, et al. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherinpositive triple-negative breast cancer. Sci Signal 7: ra15, 2014
24. Sumimoto S, Muramatsu R, Fujii S and Yamashita T. Vascular endothelial cells promote cortical neurite outgrowth via an integrin β3-dependent mechanism. Biochem Biophys Res Commun 450: 593-597, 2014
25. Nasulewicz-Goldeman A, Uszczyńska B, Szczaurska-Nowak K and Wietrzyk J. siRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells. Oncol Rep 28: 1567-1573, 2012
26. Li A, Guo Q, Kim C, Hu W and Ye F. Integrin alphaII b tail distal of GFFKR participates in inside-out alphaII b beta3 activation. J Thromb Haemost 12: 1145-1155, 2014
27. Beauvais DM and Rapraeger AC. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp Cell Res 286: 219-232, 2003
28. Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15: 195-206, 2009
29. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T and Brabletz T A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131: 830-840, 2006
30. Augoff K, Das M, Bialkowska K, McCue B, Plow EF and Sossey-Alaoui K. miR-31 is a broad regulator of β1-integrin expression and function in cancer cells. Mol Cancer Res 9: 1500-1508, 2011
31. Frijns E, Sachs N, Kreft M, Wilhelmsen K and Sonnenberg A. EGF-induced MAPK signaling inhibits hemidesmosome formation through phosphorylation of the integrin {beta}4. JBiol Chem 285: 37650-37662, 2010
32. Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC and Chapman HA. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J Biol Chem 282: 3929-3939, 2007
33. Sato T and Miwa A. Ets-1 and integrin beta3 for lung metastasis from colorectal cancer. APMIS 110: 347-353, 2002
34. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N and Bosserhoff AK. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004